<p>Brain network architecture is anticipated to influence future grey matter loss in individuals at Clinical High Risk (CHR) for psychosis. However, existing studies on grey matter structural network properties in CHR are scarce and constrained by small sample sizes. Here, we examined network topology differences comparing a) CHR versus healthy controls (HC); b) CHR who transitioned to psychosis (CHR-T) versus those who did not (CHR-NT); and c) different subsyndromes. We included structural scans from 1842 CHR individuals and 1417 HC individuals from 31 sites within the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) consortium. At the global level, CHR individuals exhibited lower structural covariance (q &lt; 0.001; Cohen’s d = 0.164) and less optimal structural network configuration than HC (lower global efficiency and clustering coefficient, d = 0.100,0.087, qs &lt;= 0.027). Though no global difference between CHR-T and CHR-NT, network distinctiveness of the frontal and temporal surface area networks was higher in CHR-T than CHR-NT (d = 0.223,0.237) and HC (d = 0.208,0.219) (qs &lt; 0.001). Network distinctiveness of the frontal cortical thickness network was lower in CHR-T (d = 0.218, q &lt; 0.001) than CHR-NT and HC (d = 0.165, q &lt; 0.001). Importantly, higher network distinctiveness was associated with worse positive symptoms in CHR-NT (frontal surface area, q = 0.008, R<sup>2</sup> = 0.013) and at trend with worse negative symptoms in CHR-T (frontal thickness, q = 0.063, R<sup>2</sup> = 0.049). Further, the brief intermittent psychotic syndrome subgroup showed more severe network alterations. Together, brain structural networks inform symptoms and the risk of transition to psychosis in CHR individuals.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR Study

  • Siwei Liu,
  • Ingrid Agartz,
  • Paul Allen,
  • G. Paul Amminger,
  • Ole A. Andreassen,
  • Peter Bachman,
  • Inmaculada Baeza,
  • Helen Baldwin,
  • Cali F. Bartholomeusz,
  • Stefan Borgwardt,
  • Sabrina Catalano,
  • Xiaogang Chen,
  • Kang Ik K. Cho,
  • Sunah Choi,
  • Tiziano Colibazzi,
  • Rebecca E. Cooper,
  • Cheryl M. Corcoran,
  • Vanessa L. Cropley,
  • Lieuwe de Haan,
  • Camilo de la Fuente-Sandoval,
  • Montserrat Dolz,
  • Bjørn H. Ebdrup,
  • Adriana Fortea,
  • Paolo Fusar-Poli,
  • Louise Birkedal Glenthøj,
  • Birte Yding Glenthøj,
  • Shalaila S. Haas,
  • Holly K. Hamilton,
  • Kristen M. Haut,
  • Rebecca A. Hayes,
  • Ying He,
  • Karsten Heekeren,
  • Wenche ten Velden Hegelstad,
  • Christine I. Hooker,
  • Leslie E. Horton,
  • Daniela Hubl,
  • Wu Jeong Hwang,
  • Michael Kaess,
  • Kiyoto Kasai,
  • Naoyuki Katagiri,
  • Minah Kim,
  • Jochen Kindler,
  • Mallory J. Klaunig,
  • Shinsuke Koike,
  • Tina D. Kristensen,
  • Yoo Bin Kwak,
  • Jun Soo Kwon,
  • Stephen M. Lawrie,
  • Irina Lebedeva,
  • Imke LJ Lemmers-Jansen,
  • Pablo León-Ortiz,
  • Ashleigh Lin,
  • Rachel L. Loewy,
  • Xiaoqian Ma,
  • Daniel H. Mathalon,
  • Patrick McGorry,
  • Philip McGuire,
  • Chantal Michel,
  • Romina Mizrahi,
  • Masafumi Mizuno,
  • Paul Møller,
  • Ricardo Mora-Durán,
  • Daniel Muñoz-Samons,
  • Barnaby Nelson,
  • Takahiro Nemoto,
  • Merete Nordentoft,
  • Dorte Nordholm,
  • Maria A. Omelchenko,
  • Lijun Ouyang,
  • Christos Pantelis,
  • Jose C. Pariente,
  • Jayachandra M. Raghava,
  • Paul E. Rasser,
  • Franz Resch,
  • Francisco Reyes-Madrigal,
  • Luis F. Rivera-Chávez,
  • Jan I. Røssberg,
  • Wulf Rössler,
  • Dean F. Salisbury,
  • Daiki Sasabayashi,
  • Ulrich Schall,
  • Jason Schiffman,
  • Andre Schmidt,
  • Lukasz Smigielski,
  • Mikkel E. Sørensen,
  • Gisela Sugranyes,
  • Michio Suzuki,
  • Tsutomu Takahashi,
  • Christian K. Tamnes,
  • Jinsong Tang,
  • Anastasia Theodoridou,
  • Sophia I. Thomopoulos,
  • Alexander S. Tomyshev,
  • Jordina Tor,
  • Peter J. Uhlhaas,
  • Tor G. Værnes,
  • Therese AMJ van Amelsvoort,
  • Dennis Velakoulis,
  • Esther Via,
  • Sophia Vinogradov,
  • James A. Waltz,
  • Christina Wenneberg,
  • Lars T. Westlye,
  • Stephen J. Wood,
  • Hidenori Yamasue,
  • Liu Yuan,
  • Alison R. Yung,
  • Michael WL Chee,
  • Paul M. Thompson,
  • Dennis Hernaus,
  • Maria Jalbrzikowski,
  • Jimmy Lee,
  • Juan H. Zhou,
  • Lieuwe de Haan,
  • Camilo de la Fuente-Sandoval,
  • Yoo Bin Kwak,
  • Therese AMJ van Amelsvoort

摘要

Brain network architecture is anticipated to influence future grey matter loss in individuals at Clinical High Risk (CHR) for psychosis. However, existing studies on grey matter structural network properties in CHR are scarce and constrained by small sample sizes. Here, we examined network topology differences comparing a) CHR versus healthy controls (HC); b) CHR who transitioned to psychosis (CHR-T) versus those who did not (CHR-NT); and c) different subsyndromes. We included structural scans from 1842 CHR individuals and 1417 HC individuals from 31 sites within the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) consortium. At the global level, CHR individuals exhibited lower structural covariance (q < 0.001; Cohen’s d = 0.164) and less optimal structural network configuration than HC (lower global efficiency and clustering coefficient, d = 0.100,0.087, qs <= 0.027). Though no global difference between CHR-T and CHR-NT, network distinctiveness of the frontal and temporal surface area networks was higher in CHR-T than CHR-NT (d = 0.223,0.237) and HC (d = 0.208,0.219) (qs < 0.001). Network distinctiveness of the frontal cortical thickness network was lower in CHR-T (d = 0.218, q < 0.001) than CHR-NT and HC (d = 0.165, q < 0.001). Importantly, higher network distinctiveness was associated with worse positive symptoms in CHR-NT (frontal surface area, q = 0.008, R2 = 0.013) and at trend with worse negative symptoms in CHR-T (frontal thickness, q = 0.063, R2 = 0.049). Further, the brief intermittent psychotic syndrome subgroup showed more severe network alterations. Together, brain structural networks inform symptoms and the risk of transition to psychosis in CHR individuals.